News
Hims & Hers Health ( NYSE: HIMS) priced its offering of $870M aggregate principal amount of 0.00% convertible senior notes due 2030 in a private offering to persons reasonably believed to be qualified ...
Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...
The latest price target for Hims & Hers Health (NYSE:HIMS) was reported by Piper Sandler on May 6, 2025. The analyst firm set a price target for $39.00 expecting HIMS to fall to within 12 months ...
Hims & Hers Health announces a $450M convertible notes offering to fuel global expansion and acquisitions. Learn about their plans and market impact.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results